1. Home
  2. LGL vs CALC Comparison

LGL vs CALC Comparison

Compare LGL & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • CALC
  • Stock Information
  • Founded
  • LGL 1917
  • CALC 2011
  • Country
  • LGL United States
  • CALC United States
  • Employees
  • LGL N/A
  • CALC N/A
  • Industry
  • LGL Industrial Machinery/Components
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGL Technology
  • CALC Health Care
  • Exchange
  • LGL Nasdaq
  • CALC Nasdaq
  • Market Cap
  • LGL 35.6M
  • CALC 22.9M
  • IPO Year
  • LGL N/A
  • CALC N/A
  • Fundamental
  • Price
  • LGL $6.96
  • CALC $1.61
  • Analyst Decision
  • LGL
  • CALC Strong Buy
  • Analyst Count
  • LGL 0
  • CALC 3
  • Target Price
  • LGL N/A
  • CALC $16.33
  • AVG Volume (30 Days)
  • LGL 41.7K
  • CALC 29.8K
  • Earning Date
  • LGL 08-12-2025
  • CALC 08-11-2025
  • Dividend Yield
  • LGL N/A
  • CALC N/A
  • EPS Growth
  • LGL 204.51
  • CALC N/A
  • EPS
  • LGL 0.08
  • CALC N/A
  • Revenue
  • LGL $4,322,000.00
  • CALC N/A
  • Revenue This Year
  • LGL N/A
  • CALC N/A
  • Revenue Next Year
  • LGL N/A
  • CALC N/A
  • P/E Ratio
  • LGL $94.50
  • CALC N/A
  • Revenue Growth
  • LGL 20.66
  • CALC N/A
  • 52 Week Low
  • LGL $5.03
  • CALC $1.42
  • 52 Week High
  • LGL $9.74
  • CALC $5.97
  • Technical
  • Relative Strength Index (RSI)
  • LGL 50.69
  • CALC 46.35
  • Support Level
  • LGL $6.90
  • CALC $1.42
  • Resistance Level
  • LGL $9.74
  • CALC $1.85
  • Average True Range (ATR)
  • LGL 1.01
  • CALC 0.15
  • MACD
  • LGL 0.02
  • CALC -0.00
  • Stochastic Oscillator
  • LGL 27.98
  • CALC 41.86

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: